Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2026-03-03 @ 10:14 PM
Study NCT ID:
NCT01337557
Status:
UNKNOWN
Last Update Posted:
2011-04-19
First Post:
2011-04-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
Sponsor:
Organization: